Waltham Compounding Center Disciplined
A meningitis outbreak at a Framingham facility prompted an inspection at the Waltham compounding center.
The Massachusetts Department of Public Health has issued a cease and desist order to a Waltham-based compounding pharmacy.
OncoMed was ordered closed on Nov. 21 “due to issues with chemotherapy drugs,” according to the DPH press release. The company has submitted a plan to correct the issue and must pass reinspection to reopen, according to the DPH.
The move came after recent unannounced inspections of the site. The meningitis outbreak at the New England Compounding Center in Framingham prompted the inspections.
In addition to OncoMed, the DPH disciplined 10 other compounding pharmacies on Tuesday, Feb. 5
Another Waltham compounding center has faced recent scrutiny. Infusion Resource surrendered its license in October of 2012 after the DPH cited it for cleanliness issues.
In addition to unannounced inspections, Gov. Deval Patrick has requested $1 million for to hire 30 additional inspectors. Also, Patrick has proposed new regulations to better supervise compounding centers.